Aptevo Therapeutics Inc. Cash Equivalents, at Carrying Value
Aptevo Therapeutics Inc. (APVO) had Cash Equivalents, at Carrying Value of $8.18 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-08-14
- 2026-06-30: Cash Equivalents, at Carrying Value $8.18M.
- 2026-03-31: Cash Equivalents, at Carrying Value $13.67M.
- 2025-12-31: Cash Equivalents, at Carrying Value $20.50M.
- 2025-09-30: Cash Equivalents, at Carrying Value $17.83M.
| Period end | Cash Equivalents, at Carrying Value | Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $8.18M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $13.67M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $20.50M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $17.83M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $1.31M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $1.28M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $7.53M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $5.79M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $7.10M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $9.59M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $13.17M 10-K · filed 2025-02-14 | |
| 2023-09-30 | $17.50M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $16.97M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $22.85M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $21.57M 10-K · filed 2024-03-05 | |
| 2022-09-30 | $18.42M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $26.93M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $32.01M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $41.20M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $47.90M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $55.90M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $30.89M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $35.38M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $23.38M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $5.57M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $9.54M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $7.49M 10-K · filed 2021-03-31 | |
| 2019-09-30 | $10.42M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $16.30M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $29.15M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $24.05M 10-K · filed 2020-03-25 | $1.59M 10-K · filed 2019-03-18 |
| 2018-09-30 | $4.11M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $3.06M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $4.24M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $997.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |